(Q53541420)

English

Megestrol acetate in advanced, progressive, hormone-insensitive cancer. Effects on the quality of life: a placebo-controlled, randomised, multicentre trial.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10492632

Megestrol acetate in advanced, progressive, hormone-insensitive cancer. Effects on the quality of life: a placebo-controlled, randomised, multicentre trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10492632

1 reference

based on heuristic

inferred from title

multicenter clinical trial

1 reference

based on heuristic

inferred from title

quality of life

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Westman G

1

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10492632

Bergman B

2

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10492632

Albertsson M

3

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10492632

Kadar L

4

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10492632

Gustavsson G

5

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10492632

Thaning L

6

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10492632

Andersson M

7

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10492632

Straumits A

8

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10492632

Jeppson B

9

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10492632

Lindén CJ

10

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10492632

Ewers SB

11

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10492632

Andersson H

12

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10492632

Mercke C

13

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10492632

Hafström L

14

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10492632

Birck O

15

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10492632

Orgum P

16

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10492632

publication date

1 April 1999

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10492632

European Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10492632

35

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10492632

4

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10492632

586-595

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10492632

The cancer anorexia-cachexia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900398-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900398-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Total parenteral nutrition in the cancer patient

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900398-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of methylprednisolone sodium succinate on quality of life in preterminal cancer patients: a placebo-controlled, multicenter study. The Methylprednisolone Preterminal Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900398-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Corticosteroid therapy of preterminal gastrointestinal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900398-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Methylprednisolone as palliative therapy for female terminal cancer patients. The Methylprednisolone Female Preterminal Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900398-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial of cyproheptadine in cancer patients with anorexia and/or cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900398-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor-associated gastroparesis: correction with metoclopramide

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900398-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900398-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900398-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900398-0

7 January 2021

based on heuristic

inferred from DOI database lookup

High- versus standard-dose megestrol acetate in women with advanced breast cancer: a phase III trial of the Piedmont Oncology Association

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900398-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900398-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900398-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900398-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life of lung cancer patients in a randomized clinical trial evaluated by a psychosocial well-being questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900398-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Coefficient alpha and the internal structure of tests

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900398-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900398-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Usefulness of megestrol acetate in cancer cachexia and anorexia. A placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900398-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900398-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved quality of life with megestrol acetate in patients with endocrine-insensitive advanced cancer: a randomised placebo-controlled trial. Australasian Megestrol Acetate Cooperative Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900398-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900398-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900398-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900398-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma concentrations of medroxyprogesterone acetate and megesterol acetate during long-term follow-up in patients treated for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900398-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A validation study of the domains of the core EORTC quality of life questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900398-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Psychometric properties and responsiveness of the EORTC quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900398-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group B.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900398-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900398-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of adrenal suppression by megestrol acetate in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900398-0

7 January 2021

based on heuristic

inferred from DOI database lookup

[Megestrol acetate in various doses in the treatment of metastatic breast carcinoma--clinical and endocrinologic studies]

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900398-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Megestrol acetate-induced adrenal suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900398-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(98)00398-0

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10492632

release_xo4ogmhzhjha5dwrkhprynamym

1 reference

https://api.fatcat.wiki/v0/release/xo4ogmhzhjha5dwrkhprynamym

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10492632

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53541420&oldid=1842643964"